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Summary Dysplasia in the upper gastrointestinal tract carries a risk of invasive malignant change. Surgical
excision of the affected organ is the only treatment available. Photodynamic therapy has been shown to be
promising in the treatment of early and superficial tumours and may be useful for the ablation of dysplastic
mucosa. Because of the diffuse nature of the disease, such treatment would necessarily involve destruction of
large areas of mucosa and it is desirable to confine its effect to the mucosa in order that safe healing can take
place. By means of photometric fluorescence microscopy, we have studied the pattern of photosensitisation in
the normal rat stomach using di-sulphonated aluminium phthalocyanine (AlS2Pc) and 5-aminolaevulinic acid
(ALA) as photosensitisers. AlS2Pc resulted in a panmural photosensitisation of the gastric wall with the
highest level encountered in the submucosa. The mucosa and muscularis propria were sensitised to equal
extent. Following light exposure, a full thickness damage resulted. ALA is a natural porphyrin precursor and
exogenous administration gave rise to accumulation of protoporphyrin IX (PPIX) in the cells. The resultant
pattern of photosensitisation was predominantly mucosal and its photodynamic effect was essentially confined
to the mucosa. ALA produced a selective photosensitisation of the gastric mucosa for its photodynamic
ablation with sparing the underlying tissue layers.
High grade epithelial dysplasia of gastric type mucosa wheth-
er in the stomach or oesophagus carries a risk of invasive
malignant change (Farrands et al., 1983; Skinner et al., 1983;
Offerhaus et al., 1984; Schmidt et al., 1985; Hamilton &
Smith, 1987; Atkinson, 1989). In the stomach, dysplastic
changes have been described in association with previous
gastric surgery (Schrumpf et al., 1977; Farrands et al., 1983;
Offerhaus et al., 1984 & 1989), as well as gastric polyps (Aste
et al., 1986). In its severe form, the malignant potential is
high (Ming et al., 1984). In the oesophagus this condition
often arises from Barrett's epithelium. There is no satisfac-
tory treatment for this condition apart from surgical excision
of the affected region of the organ concerned if this risk is
significant (Skinner et al., 1983; Ferrands et al., 1983; Dent,
1989; Atkinson, 1989). Surgery is a major procedure and
often not a viable option. Thermal laser ablation carries the
risk of viscus perforation (Barr et al., 1987b) and is not
practical because of the diffuse and multicentric nature of
dysplasia. Photodynamic therapy (PDT) of tumours involves
the local activation of a preadministered photosensitiser by
light of a specific wavelength matched to the absorption
characteristic of the photosensitiser used. The activated pho-
tosensitiser subsequently give rise to production of cytotoxic
singlet oxygen species (Weishaupt et al., 1976). The mech-
anism of cell kill is by chemotoxicity and there is less
likelihood of viscus perforation (Barr et al., 1987b). PDT has
been used to treat gastrointestinal tumours (Kato et al., 1986;
Jin et al., 1987; Patrice et al., 1990; Krasner et al., 1990).
Because of limited transmittance of light in tissue, it has been
shown to be most effective in the treatment of small and
early tumours (Kato et al., 1986; Jin et al., 1987; Krasner et
al., 1990). Epithelial dysplasia is an early superficial form of
neoplastic lesion which is confined only to the mucosa and
PDT may be a useful treatment modality for this condition.
Due to its diffuse nature, treatment would necessarily involve
destruction of large areas of mucosa. It is thus essential to
limit the photodynamic effect to the mucosa to minimise
complication and enhance prompt and safe healing. Photo-
dynamic effect is local and only occurs when the products of
the local light dose and photosensitiser concentration exceeds
a threshold (Cowled & Forbes, 1985). In addition, because of
photodegradation of photosensitiser by the activating light,
the local tissue concentration of photosensitiser has to exceed
a particular level irrespective of light dose before photo-
dynamic action can take place (Potter et al., 1987). When a
sufficient differential photosensitiser distribution exist be-
tween mucosa and underlying structure, it is possible to
produce a predominant photodynamic effect in the mucosa
by keeping the concentration of photosensitiser in the
mucosa above this threshold while that in the underlying
tissue below it. This approach has been adopted experiment-
ally in the bladder, and the resultant photodynamic effect
causes minimal disruption of both the anatomical and func-
tional integrity of the bladder while still achieving the desired
objective of complete mucosal ablation (Pope & Bown,
1991a).
We have previously reported the efficacy of aluminium
sulphonated phthalocyanine (AlSPc) as a photosensitiser in
both normal tissue and tumours (Barr et al., 1987a; Tralau et
al., 1987; Barr et al., 1990) as well as its advantages over
haematoporphyrin derivative with respect to cutaneous pho-
totoxicity (Tralau et al., 1989). We have further observed
that PDT using AlSPc does not compromise the mechanical
strength of the normal colon (Barr et al., 1987b). Most of the
PDT studies using AlSPc have been carried out using a
mixture of compounds with different degree of sulphonation
(range of 1 to 4 sulphonated groups with the average being
3.2). From recent studies, di-sulphonated phthalocyanine has
been shown to be a more potent photosensitiser both in vitro
and in vivo (Paquette et al., 1988; Berg et al., 1989; Chan et
al., 1990; Chatlani et al., 1991). For these reasons, we have
chosen to use the di-sulphonated aluminium phthalocyanine
(AlS2Pc) for this study.
ALA in itself is not a photosensitiser. It is a natural
porphyrin precursor and its synthesis by living cells is the
first committed step which will eventually lead to haem for-
mation. In this biosynthetic pathway, the rate limiting step is
that involved in the synthesis of ALA which is controlled by
a regulatory feedback inhibition (Marriott, 1968; Rimington,
1966). By administering a large quantity of exogenous ALA
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both to in vitro systems as well as whole animals, it has been
shown that the natural regulatory mechanism can become
overloaded and as a result, porphyrin intermediates of the
biosynthetic pathway, particularly protoporphyrin IX
(PPIX), accumulate (Malik & Djaldetti, 1979; Sima et al.,
1981). PPIX is a potent photosensitiser. Malik & Lugaci
(1987) and Kennedy's group (Divaris et al., 1990) have
shown that enough PPIX can be synthesised this way to
produce a photodynamic effect both in vitro and in vivo.
More recently, exogenous ALA applied topically has been
shown to be effective in the photodynamic treatment of
various cutaneous cancers (Kennedy et al., 1990; Wolf &
Kerl, 1991).
Although in theory all nucleated cells exhibiting aerobic
metabolism capable of haem synthesis are liable to become
photosensitised, Divaris found that following administration
of exogenous ALA to mice, there was a marked difference in
the level of photosensitisation in the various tissue structures
in the skin as studied by fluorescence microscopy. The
epidermal cells and cells of the pilosebaceous apparatus were
markedly fluorescent as compared to the dermis (Divaris et
al., 1990). The same group has also reported that in the
bladder and uterus, ALA administration resulted in preferen-
tial photosensitisation of the mucosa and endometrium over
the other underlying structures of the respective organs.
These findings prompted us to investigate ALA as a possible
photosensitiser for photodynamic ablation of gastric mucosa.
Materials and methods
Photosensitiser
AlS2Pc was purified and analysed using high performance
liquid chromatography (HPLC) at the Department of Chem-
istry, Imperial College of Science Technology and Medicine.
The di-sulphonated fraction of AlS2Pc was separated from a
mixture prepared by the oleum sulphonation of aluminium
phthalocyanine chloride, using reverse phase liquid chroma-
tography. This fraction contained a range of di-sulphonated
isomers dominated by the most hydrophobic component
which comprised 60 ± 5% of its integrated HPLC (Ambroz
et al., 1991). The photosensitiser was made up in 0.1 molar
sodium hydroxide and phosphate buffered saline and admin-
istered intravenously via the tail vein. ALA was obtained as a
hydrochloride (formular weight = 167.6) in 98% pure powder
form from Sigma Chemical Company Limited (Poole, UK).
It was dissolved in phosphate buffered saline for administra-
tion.
Animals
All studies were performed on female Wistar rats supplied by
the Imperial Cancer Research Fund. Their age ranged from 4
to 8 weeks and their weight ranged from 100 g to 200 g.
Injections of photosensitisers were carried out under intra-
muscular Hypnorm (fentanyl and fluanisone) anaesthesia.
The concentration of photosensitiser was adjusted to main-
tain the volume of injection between 0.3-0.5 ml to ensure
accurate injection. Photodynamic therapy was carried out
during laparotomy under intramuscular Hypnorm and diaze-
pam anaesthesia.
Distributions ofphotosensitisers in the stomach
This was studied by means of fluorescence microscopy and
photometry. After administration of photosensitiser, animals
were killed at a range of times from 15 min to 2 weeks. A
small disc of stomach wall was excised from the glandular
stomach along the greater curvature just distal to the limiting
line and immediately frozen by submerging in a bath of
isopentane (2-methylbutane) prechilled in liquid nitrogen.
The snap frozen tissue samples were then stored in liquid
nitrogen until sectioned. Tissue blocks were- mounted on
OCT medium (tissue tek II embedding compound, BDH)
and 10pm sections were cut using a Cryocut E microtome
(Reichert-Jung). The slides were stored in a freezer at - 20°C
and only allowed to thaw just prior to fluorescence micros-
copy. An inverted microscope (Olympus IMT-2) with
epifluorescence and phase-contrast attachments was used as
described previously (Chan et al., 1989). Fluorescence excita-
tion came from an 8 mW helium-neon laser (632.8 nm). The
beam was delivered by a liquid light guide and through a
10 nm band-pass filter centred at 633 nm to remove ext-
raneous light onto the dichroic mirror (Omega Optical Inc.)
for epifluorescence study. The phthalocyanine fluorescence
was detected between 665 and 700 nm using a combination
of band-pass (Omega Optical Inc.) and long-pass (Schott
RG665) filters. The fluorescence signal was detected by a
highly sensitive cryogenically cooled CCD (charge-coupled
device) camera (Wright Instruments, model 1, resolution
400 x 600 pixels) fitted to the microscope. This signal was
processed by an IBM personal computer into a falsely
colour-coded microscopic image of the section depicting the
mean signal counts per pixel. The software also allowed
quantitative analysis of the signal by calculating the mean
fluorescence count and its standard deviation within any
chosen area on the fluorescence image. Using- a ten times
objective of the microscope, a view of the entire cross section
of the stomach was included. The mucosa, submucosa and
muscularis propria were usually readily discernable on the
fluorescence image. Three representative areas over each tis-
sue layer at least 100 x 100 pixels in size were chosen for
analysis on each section. Conventional light microscopy of
the stained serial section of the specimen also helped to
enable accurate identification of the various microscopic
structures. As PPIX and AlS2Pc have very different
fluorescence efficiency using 633 nm excitation, exposure time
of the specimen to the exciting laser light was set to produce
a comparable range of measurements (7.5 seconds for AlS2Pc
and 25 seconds for ALA). Fluorescence was measured arbit-
rarily as counts per pixel (20 photoelectrons per count; quan-
tum efficiency = 0.5 at this wavelength). The longer exposure
time used for ALA resulted in higher tissue autofluorescence
than that for AlS2Pc. All fluorescence measurements were
corrected for their respective autofluorescence (as measured
on control specimens) of each respective layer of tissue with
the respective exposure time for each photosensitiser. After
fluorescence microscopy, specimens were fixed in formalin
and stained with haemotoxylin and eosin. Both the falsely
coloured coded fluorescence image and the light microscopic
image of the subsequently stained section were photographed
for comparison (Figure 3a, 3b, 4a and 4b). All studies with
AlS2Pc were carried out using 5 mg kg-' (6.5 ymol kg-') of
AlS2Pc. As the conversion of ALA to the photoactive PPIX
is dose dependent, a range of doses (20 mg kg-' (0.119 mmol
kg-'), 100mgkg-' (0.597 mmol kg-') and 200mg kg-'
(1.193 mmol kg-') were employed.
Photodynamic therapy
The light source used was a pulsed (12 kHz) copper vapour
pumped dye laser (Oxford Lasers). In the AlS2Pc group, the
output was tuned to 675 nm (peak absorption for AlS2Pc)
and delivered via a 200 ytm fibre threaded into the stomach
through the forestomach and held just touching the mucosa
of the glandular stomach. The fibre was maintained at ap-
proximately 900 to the mucosal surface. The rest of the
abdominal viscera were shielded from forward light scatter
by interposition of a piece of opaque paper. Only one point
was treated in each animal. Power output from the fibre tip
was 50 mW and the total irradiation time 1000 sec giving a
total energy delivery of 50 J per animal. In one sub-group, all
animals were sensitised with 5 mg kg-' of AlS2Pc and then
exposed to laser light at a range of times from 1 to 48 h
following sensitisation. In the other sub-group, animals were
sensitised with AlS2Pc at a range of doses from 0.5 mg kg-l
to 5 mgkg-' and then exposed to laser light 2 h later. In the
ALA group, the laser was tuned to 630 nm and the same
power and exposure time were used. Two sub-groups of454 C.S.LOHetal.
animals were treated with ALA photosensitisation. In one
sub-group, all animals were given 200 mg kg-' of ALA and
light exposure was effected at a range of time from 30 min to
8 h. In the other sub-group, animals were sensitised with
different doses of ALA (1 mg kg-', 5 mg kg-', 20mg kg-',
lO0mgkg'1, 200mgkg'1 and 400mgkg-1) and then ex-
posed to laser light at the time of peak photosensitisation of
the respective doses as determined from fluorescence photo-
metry. Fluorescence photometry was not carried out with
1 mg kg' and 5 mg kg-' of ALA because with these doses,
the fluorescence yield was too low relative to the background
tissue fluorescence to provide sufficient contrast for detection
using our system. Control unsensitised animals were irrad-
iated using similar parameters to exclude thermal effects.
Treated areas were marked with two silk sutures placed
along the greater curve at 1 cm proximal and 1 cm distal to
the point of contact of the laser fibre to ease subsequent
identification. Animals were allowed to recover and kept in
standard laboratory conditions until sacrificed at 72 h. On
killing the animal, the stomach was immediately excised and
opened along the lesser curve for macroscopic inspection.
The specimens were laid out on a piece of card and the size
of the PDT induced lesions were determined by taking the
mean of the longest diameter and the broadest diameter of
the lesion (Barr et al., 1987a). The specimen was then fixed in
formalin and prepared for conventional light microscopy.
Results
Fluorescencephotometry
Fluorescence spectroscopy using a Perkin-Elmer LS-5B spec-
trofluorimeter (excitation at 400 nm) of an ex vivo specimen
of stomach from a rat sensitised with 200 mgkg-' of ALA
was carried out and the spectrum obtained was found to be
consistent with the fluorescence emission spectrum of PPIX
as also found by Divanis et al. (1990). Following administra-
tion of 5 mgkg-' of AIS2PC, fluorescence reached a peak at
1 h and rapidly declined in the first 48 h (Figure la). By 2
weeks, the fluorescence signal approached that of the control
specimen. At all time points, the highest uptake of AlS2Pc
was seen in the submucosa. Mean uptake by the submucosa
was approximately twice that of the mucosa and muscularis
propria. With 200 mg kg-' ofALA, the fluorescence signal in
the mucosal layer rose rapidly to a peak at 3 h while signal
over the other layers rose much less (Figure 1lb). Peak
fluorescence was achieved earlier with the 20 mg kg of
a
ALA as compared to higher doses and the trend suggested
an earlier fluorescence peak with 100 mg kg as compared to
200 mg kg-' (Figure 2). Although the level of maximum
fluorescence increased with the dose of ALA administered,
this relationship was not a linear one and the peak fluor-
escence level achieved with 200 mg kg-' of ALA was only
marginally higher than that with 100 mg kg'- . Fluorescence
declined very rapidly and almost reaching background level
by 6 to 8 h.
The microscopic distribution of fluorescence after adminis-
tration of 5 mg kg-' of AlS2Pc is represented in Figure 3a
and b. Highest levels of fluorescence were seen in the sub-
mucosal layer and particularly around blood vessels. Fluor-
escence levels in the mucosa and muscularis were comparable
and both lower than that found in the submucosa. With
ALA however, the resultant PPIX fluorescence was predomi-
nantly over the mucosa (Figure 4a and b) with very little
fluorescence seen over the submucosa and muscularis pro-
pria. At higher magnification, AlS2Pc fluorescence was high-
est around the periphery of the epithelial cells in the mucosa
suggesting that AlS2Pc was largely extracellular (Figure 5a).
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Figure 1 Mean level of fluorescence (± s.d.) of the layers of the gastric wall after intravenous administration of 5 mg kg-
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Figure 3 a, Fluorescence image of a frozen section of gastric wall 4 h after intravenous administration of 5 mgkg-' of AlS2Pc. The upper colour bar represents the fluorescence scale (Black = 25 counts per pixel; White = 256 counts per pixel). Scale: the bar in the right bottom corner represents 100rim. (muc = mucosa; mus = muscularis propria; sm = submucosa). b, Micrograph of section in a after H-E staining showing the corresponding mucosal, submucosal and muscular layer. Scale: the bar in the right bottom corner represents 100Im. (muc = mucosa; mus = muscularis propria; sm = submucosa).
ALA induced PPIX fluorescence was, however, intracellular
in location and mainly perinuclear (Figure 5b).
The relative level of fluorescence of the mucosa and mus-
cularis propria achieved following administration of both
compounds differed markedly. With AlS2Pc, apart from
immediately following administration when a significant
quantity ofphotosensitiser was still in the intravascular com-
partment, the ratio of fluorescence between the mucosa and
the muscularis propria remained at approximately 1 through-
out. In contrast, after administration of ALA, the ratio of
fluorescence level between mucosa and muscle varied with
time (Figure 6). With all doses of ALA, this ratio rose to a
peak in excess of 14 one hour after administration. With
20 mgkg-', of ALA, this ratio fell back rapidly to almost
unity at 2 h. When higher doses of ALA were given, the high
fluorescence ratio was sustained over a longer duration and
with the dose of 200 mgkg-', did not reach unity until 8 h
after administration.
Photodynamic therapy
No macroscopic lesion was seen in the control groups al-
though on close microscopic scrutiny, a small area of muco-
sal necrosis comparable to the diameter of the fibre could be
found. In contrast, photodynamic lesions were macroscop-
ically obvious if present. After photosensitisation with 5 mg kg'I of AlS2Pc, maximum damage occurred when animals
were exposed to light between 1 and 3 h after sensitisation
(Figure 7a) which correlated relatively well with the time
peak of AlS2Pc fluorescence. Using 200 mgkg-' of ALA,
apart from a lesser extent of damage produced when light
exposure occurred at I hour after administration, the extent456 C.S. LOH et al.
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Figure 4 a, Fluorescence image of a frozen section of gastric wall 3 h after intravenous administration of 200 mg kg- of ALA. The upper colour bar represents the fluorescence scale (Black = 25 counts per pixel; White = 256 counts per pixel). The mucosal layer is brightly fluorescent while fluorescence levels in all the other layers of the gastric wall are little above background. Scale: the bar in the right bottom corner represents 100jAm. (muc = mucosa; mus = muscularis propria; sm = submucosa). b, Micrograph of section in a after H-E staining showing the corresponding mucosal, submucosal and muscular layer. Scale: the bar in the right bottom corner represents 100rLm. (muc = mucosa; mus = muscularis propria; sm = submucosa).
of damage appeared to plateau off subsequently when light
exposure occurred between 1 and 6 h after administration
(Figure 7b).
The extent ofphotodynamic damage produced with AlS2Pc
photosensitisation varied with the dose administered. No
photodynamic lesion was produced at the sensitiser dose of
0.5 or 1 mg kg-'. Above 1 mg kg-', the size of the lesion
produced appeared to correlate with increasing dose of
AlS2Pc. This dose effect was not seen with ALA photosen-
sitisation. No PDT damage was evident when the animals
were sensitised with I mg kg-' or 5 mgkg-' of ALA. How-
ever, the mean diameter of the PDT lesion remained rela-
tively constant despite a 20 times increase in the dose of
ALA given from 20 mg kg-' to 400 mg kg-' (Figure 8). The
threshold dose of ALA for photodynamic effect in the
stomach lies between 5mgkg-' and 20mgkg-'. Histology at 72h after PDT with 5mgkg-' of AlS2Pc showed a full thickness necrosis of the gastric wall with
widespread infiltration of acute inflammatory cells (Figure 9a). The same transmural necrosis was seen with doses of
3 mg kg-' and 2 mgkg-'. Two weeks after PDT, the dead
tissue has been demolished either by sloughing or resorption leaving a full thickness defect which was bridged by extensive
deposition of scar tissue and new collagen on the serosal
aspect. The mucosal defect was re-epithelialised initially-with
mucus secreting glandular epithelium but by 16 weeks after
PDT, there were parietal cells and smooth muscle regenera- tion. No microscopic evidence ofphotodynamic damage wasPHOTODYNAMIC EFFECT OF ALS2PC AND ALA IN NORMAL STOMACH 457
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Figure 5 a, Grey scale fluorescence micrograph of a frozen section of gastric mucosa 4 h after intravenous administration of
5 mg kg-' of AlS2Pc showing high level of fluorescence mainly around the periphery of the epithelial cells. Scale: the bar in the
lower right corner represents 25 jim. b, Grey scale fluorescence micrograph of a frozen section of gastric mucosa I h after
intravenous administration of 200 mg kg-' ALA showing high level of fluorescence mainly inside the cells but outside the nuclei.
Scale: the bar in the lower right corner represents 25 jLm.
seen with 1 mg kg-' of AlS2Pc. The photodynamic effect of
ALA photosensitisation was predominantly confined to the
mucosa with extensive necrosis of mucosal epithelial cells.
There was some damage to the muscularis propria when a
dose of 200 mg kg-' was used but the layer remain viable.
With the dose of 20 mg kg-' however, the submucosa and
muscularis were hardly affected (Figure 9b) and the resultant
healing involve minimal scar tissue formation.
Discussion
Dysplasia in the alimentary tract is a difficult clinical prob-
lem. Although-its malignant potential is well known, many
clinicians are reluctant to advise excisional surgery in the
absence of invasive malignant change. PDT may be an
effective but less invasive treatment for this condition. The
ideal goal would be the selective destruction of only the
dysplastic mucosa. Barr et al. (1990) had shown that with
AlSPc truly selective tumour necrosis (i.e. necrosis of tumour
tissue but not the adjacent normal tissue from which the
tumour arise) could be produced by judicious manipulation
of treatment parameters in such a way that the photosen-
sitiser concentration in the normal tissue fell below the
photodynamic threshold while that in the tumour tissue
remained above it. The volume of tumour necrosis produced
was however very small. This was due to the small
therapeutic ratio of conventional photosensitiser (2:1)
between tumour and adjacent normal tissue (Tralau et al.,
1987). In addition, this true selectivity could only be applied458 C.S. LOH et al.
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to part of the tumours treated, and did not apply to the
region where the tumour was invading normal tissue (Barr et
al., 1991). This was because there was always more photosen-
sitiser in the stroma than malignant cells and shut down of
small vessels would inevitably damage normal tissue along
with tumour. Although some workers had shown
qualitatively that haematoporphyrin derivative could localise
in benign tumours (Dal Fante et al., 1988; Gregorie et al.,
1968), carcinoma in situ (Cortese et al., 1979; Gray et al.,
1967) and severe dysplasia (Benson et al., 1982), quan-
titatively this differential was not likely to exceed that seen
between established tumour and its normal tissue. Clearly,
without a substantial therapeutic ratio between dysplastic
and normal tissue, true selective ablation of dysplastic
mucosa would be impractical clinically. Selectivity between
mucosa and normal muscle is likely to be far more important
than selectivity between dysplastic mucosa and normal
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mucosa. As long as large areas of mucosal defect heals safely
with healthy epithelium, the net result will be selective dest-
ruction ofdysplastic mucosa. The importance ofpreservation
of underlying muscle in photodynamic mucosal ablation can
be seen in the bladder where it has been shown that when
photodynamic damage is localised to the mucosa, the under-
lying muscle layer retains its structural as well as functional
integrity (Pope & Bown, 1991a). The aim of this study is to
produce selective mucosal necrosis with sparing of the under-
lying layers and study the healing that takes place after such
a specific injury.
In the first part of this study, we have demonstrated some
of the pharmacokinetics of AlS2Pc in the normal stomach.
We have established the threshold photodynamic dose of
AlS2Pc as well as the time of maximum photosensitisation.
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Figure 8 Mean diameter (± s.d.) of the photodynamic damage
(50 mW x 1000 s, 675 nm wavelength for AlS2Pc and 630 nm
wavelength for ALA) in normal glandular gastric mucosa as a
function of the administered dose of photosensitisers. All animals
were exposed to light at the time of peak fluorescence for the
respective photosensitisers as determined from fluorescence
photometry. Each value represents the mean in two to three
animals.
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Figure 7 a, Mean diameter ( ± s.d.) of gastric ulcer produced in the normal glandular stomach mucosa after light exposure
(675 nm, 50 mW x 1000 s) at the various times following sensitisation with 5 mg kg-' AlS2Pc. Each value represents the mean of
diameters in four animals. b, Mean diameter (± s.d.) of gastric ulcer produced in the normal glandular stomach after light exposure
(630 nm, 50 mW x 1000 s) at the various times following sensitisation with 200 mg kg-' ALA. Each value represents the mean of
diameters in four animals.
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Figure 9 a, Micrograph of a H-E stained section of a typical lesion 3 days after photodynamic therapy with 5 mg kg- AlS2Pc
(50 mW red light at 675 nm for 1000 s 2 h after administration). The section shows extensive full thickness necrosis with widespread
infiltration of acute inflammatory cells. Scale: the bar in the lower right corner represents 250gm. (muc = mucosa; mus = mus-
cularis propria; sm = submucosa). b, Micrograph of a H-E stained section of a lesion in the normal rat stomach produced 3 days
after photodynamic therapy with ALA photosensitisation. 20 mgkg-' of ALA was injected intravenously and the stomach exposed
to 50 mW red light at 630 nm for 1000 s 1 h after administration. The section shows extensive mucosal necrosis with widespread
infiltration of acute inflammatory cells. The submucosal and muscular layer appear intact. Scale: the bar in the lower right corner
represents 250gm. (muc = mucosa; mus =muscularis propria; sm = submucosa).
Our group has previously shown that AlS2Pc distribution in
tissue is dependent on the level of sulphonation (Chatlani et
al., 1991). The use of the more hydrophobic di-sulphonated
preparation in this study was an attempt to localise AlSPc to
the more cellular mucosal layer. However, what we found
was sensitisation of the full thickness of the stomach wall.
We were somewhat surprised to see little differential distribu-
tion between the mucosa and the muscularis propria as
significant preferential mucosal sensitisation had been
observed in bladder wall due to longer retention of AlSPc in
the mucosa (Pope et al., 1991b). In vitro studies had demon-
strated that AlS2Pc was readily taken up into cells in culture
and the degree of this uptake increases linearly with lipo-
philicity. (Berg et al., 1989). The subcellular localisation of
AlS2Pc in vivo after intravenous administration is unknown,
althought this study demonstrates that it is predominantly
peripheral around the gastric epithelial cells and probably
extracellular. Parietal cells of gastric mucosa secrete acid. As
hydrogen ions are secreted into the gastric lumen, bicar-
bonate and hydroxyl ions are transported across the base-
ment membrane into the interstitium in order to preserve
cellular neutrality. The resultant higher pH of the extracel-
lular fluid can reduce the lipid solubility of the AlS2Pc
leading to a reduction in the AlS2Pc partitioning between the460 C.S. LOH et al.
intra and extracellular compartment (Berg et al., 1989). This
could explain the extracellular location of AlS2Pc in the
gastric mucosa and the lack of preferential retention of
AlS2Pc by the mucosa as compared to the muscular layer in
contrast to findings in other hollow organs such as the
bladder as discussed above. In the light of the distribution of
AlS2Pc in the normal stomach wall, its panmural photody-
namic effect is perhaps not surprising.
Following administration of exogenous ALA, accumula-
tion of PPIX is dependent on the differential rate of its
synthesis versus its conversion to haem by the various tissues.
The greater accumulation of PPIX seen in the mucosal cells
can either be due to a differentially larger PPIX synthesising
capacity or a lower conversion capacity of PPIX to haem by
mucosal cells as compared to the smooth muscle and connec-
tive tissue cells. Haem forms an integral part ofvarious haem
proteins which include haemoglobin, myoglobin, cytochromes
and catalase. As haem requirement by different cells varies,
the capacity for its synthesis can be expected to vary with
different tissues. Sardesai and his colleagues (1964) measured
the extracted porphyrins from various tissue following incu-
bation with ALA and obtained the highest level of extracted
porphyrins from nucleated chicken erythrocytes, especially
haemolysed. In non haemopoietic tissue, higher levels were
obtained from liver, and in decreasing order, kidney, brain
and heart. They suggested that the porphyrin synthesis
observed correlated with the rate and quantity of haem
protein synthesis by the various tissues. Although porphyrin
metabolism in other tissues has not been completely eluci-
dated and the precise determinants for the larger capacity of
porphyrin synthesis and accumulation in some tissues re-
mains unclear, it is notable in the alimentary tract that the
mucosa has the highest rate ofturnover and is probably most
metabolically active. By inference, neoplastic tissue may
prove to have an even higher capacity in this respect. Using
the techniques of tissue explant culture, Navone et al. (1990)
were able to show that human breast cancer showed a 20-
fold enhancement of enzymatic activity for porphyrin syn-
thesis from ALA as compared to normal breast tissue
between the stages ofporphobilinogen and coproporphyrino-
gen formation. For purposes of selective PDT of tumours,
however, the absolute quantity of the photoactive PPIX
accumulated in the respective tissues is a more important end
point. Preliminary studies on a colonic tumour model in rats
showed that significantly more PPIX was synthesised in the
tumour cells than in normal tissue (Bedwell et al., 1992).
The histological location of photodynamic damage with
both ALA and AlS2Pc appears to reflect the distribution of
photosensitiser across the gastric wall as observed with
fluorescence microscopy. The mechanism of cytotoxicity is,
however, different. There is good evidence to suggest that the
photodynamic effect on cells from AlS2Pc is secondary to
damage to the microvasculature (Nelson et al., 1988; Mil-
anesi et al., 1987). With ALA however, the synthesised PPIX
is intracellular and the mechanism of cell death results from
direct cellular photosensitisation. This is advantageous as this
latter mechanism is less likely to disrupt the supporting tissue
and vascular structure of the mucosa and this may lead to
better healing with less scarring. Applying this to small nests
of tumour cells, it would be possible to eradicate these
without effecting adjacent normal cells if differential photo-
sensitisation exists whereas with AlS2Pc, damage to small
vessels would necessarily result in necrosis of the entire field
where these nest of tumour cells reside.
The kinetics of photosensitisers from the two substances is
quite different. AlS2Pc is an exogenous photosensitiser and its
resultant phototoxicity is dose related. ALA, however, is not
a photosensitiser in its own right. Phototoxicity requires its
conversion to PPIX. In the presence of infinite capacity for
this conversion, the yield of PPIX at any time point should
correlate with the amount of ALA supplied. As each cell has
a finite capacity for conversion of ALA to PPIX, when this
capacity becomes saturated anywhere along its biosynthetic
pathway, the time and dose correlation is lost (Figure 2). The
lack of correlation between the time of maximum photo-
dynamic effect and that of maximum tissue levels of PPIX
also contrasts with the finding with AlS2Pc. This might be
due to production of other porphyrin species which are good
photosensitisers but not well detected by our system. Alterna-
tively, the intracellular location of protoporphyrin IX to
sensitive organelles at certain times during the biosynthetic
process might also cause an increased sensitivity of the cells
to photodynamic effect during those times. Unlike AlS2Pc,
the extent of photodynamic effect of ALA failed to show a
correlation with dose above its threshold photodynamic dose.
There were several possible explanations. Firstly, a substan-
tial amount of ALA is excreted unchanged in the urine in the
first few hours after exogenous administration (Berlin et al.,
1956) and this excretion is likely to be dose related. Secondly,
the PPIX biosynthetic pathway could have been saturated by
a relatively low dose of exogenous ALA. Finally, the differ-
ent site and mechanism of photodynamic action with ALA
induced photosensitisation could result in a different dose
response relationship.
As shown in our study, ALA provides a significant
therapeutic ratio between the mucosa and muscle (in excess
of 10:1). This means that with appropriate treatment para-
meters extensive mucosal necrosis can be produced with spar-
ing of the underlying muscle layer. We have also shown that
photodynamic destruction of normal mucosa is followed by
complete regeneration of normal healthy mucosa. The next
step, using a suitable animal model, will be to investigate the
healing following photodynamic ablation of dysplastic muc-
osa. Although we confined our current experiments to the
production of focal lesions, large areas of selective mucosal
necrosis should be producible in the stomach with appropri-
ate light delivery. The observation of late parietal cells
regeneration in the regenerated mucosa following PDT is
encouraging as it suggests that full mucosa secretory function
can be preserved but safe healing of large areas of gastric
mucosal necrosis will still require experimental validation.
ALA has the added advantage of causing only short lived
photosensitisation (Divaris et al., 1990) and hence cutaneous
phototoxic side effects are unlikely after 24 h. This should
open up new possibilities for treatment of large tumours with
multiple treatment sessions. Thus a certain volume of tumour
can be necrosed with each treatment, exposing deeper fresh
tumour for further PDT.
In conclusion, we have shown that by using parenterally
administered ALA, we are able to produce a selective photo-
sensitisation of gastric mucosa with sparing of the other
tissue layers of the stomach and further studies using appro-
priate gastric tumour models are now warranted.
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